PI
SCMP

Putnam Investments’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Putnam Investments’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-119,300
Closed -$1.41M – 1239
2017
Q3 		$1.41M Buy
+119,300
New +$1.34M ﹤0.01% 854
2017
Q2 		– Sell
-381,439
Closed -$4.2M – 1400
2017
Q1 		$4.2M Buy
381,439
+5,976
+2% +$69.4K 0.01% 655
2016
Q4 		$5.09M Buy
375,463
+275,073
+274% +$3.84M 0.01% 580
2016
Q3 		$1.24M Sell
100,390
-103,097
-51% -$1.21M ﹤0.01% 972
2016
Q2 		$2.23M Sell
203,487
-13,334
-6% -$149K 0.01% 894
2016
Q1 		$2.37M Buy
216,821
+80,287
+59% +$1.01M 0.01% 900
2015
Q4 		$2.36M Buy
136,534
+23,366
+21% +$419K 0.01% 930
2015
Q3 		$2.25M Sell
113,168
-14,731
-12% -$338K 0.01% 960
2015
Q2 		$2.1M Sell
127,899
-1,043
-0.8% -$18.1K ﹤0.01% 1047
2015
Q1 		$2.01M Sell
128,942
-407,606
-76% -$6.32M ﹤0.01% 1054
2014
Q4 		$7.66M Sell
536,548
-236,838
-31% -$2.5M 0.02% 601
2014
Q3 		$5.03M Sell
773,386
-3,338
-0.4% -$22.2K 0.01% 770
2014
Q2 		$5.36M Sell
776,724
-21,617
-3% -$153K 0.01% 760
2014
Q1 		$5.71M Buy
798,341
+527,102
+194% +$4.51M 0.01% 707
2013
Q4 		$2.55M Buy
+271,239
New +$1.93M 0.01% 980

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Putnam Investments's SCMP Position: Q4 2017 in Review

Putnam Investments sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 119,300 shares — an estimated $1.41M sold.

Putnam Investments first reported a position in SCMP in Q4 2013 and held it in 15 quarters. The position peaked at $7.66M in Q4 2014. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

  • Putnam Investments reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Putnam Investments sold 119,300 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $1.41M.
  • Putnam Investments first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2013 and held it in 15 quarters.
  • Putnam Investments's Sucampo Pharmaceuticals, Inc. position peaked at $7.66M in Q4 2014.
  • 188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Putnam Investments's 13F filing for Q4 2017, filed 14 Feb 2018.